XML 33 R17.htm IDEA: XBRL DOCUMENT v2.4.0.8
Summary of Business and Significant Accounting Policies (Tables)
9 Months Ended
Mar. 31, 2014
Schedule of Information Related to Geographic Areas

Information relating to our geographic areas for the three and nine months ended March 31, 2014 and 2013 is as follows (unaudited, in thousands):

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

March 31,

 

 

March 31,

 

 

2014

 

 

2013

 

 

2014

 

 

2013

 

Total Revenue:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

North America

$

9,562

 

 

$

9,372

 

 

$

27,435

 

 

$

24,025

 

EMEA

 

8,127

 

 

 

6,014

 

 

 

22,783

 

 

 

16,685

 

Asia Pacific

 

337

 

 

 

74

 

 

 

1,155

 

 

 

210

 

 

$

18,026

 

 

$

15,460

 

 

$

51,373

 

 

$

40,920

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating Income (Loss):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

North America

$

(569

)

 

$

1,264

 

 

$

(1,607

)

 

$

1,379

 

EMEA

 

1,118

 

 

 

890

 

 

 

1,474

 

 

 

1,497

 

Asia Pacific*

 

(1,237

)

 

 

(1,243

)

 

 

(3,221

)

 

 

(3,779

)

 

$

(688

)

 

$

911

 

 

$

(3,354

)

 

$

(903

)

*

Includes costs associated with corporate support.

Schedule of Identifiable Tangible Assets Corresponding to Geographical Areas

In addition, identifiable tangible assets corresponding to our geographic areas are as follows (unaudited, in thousands):

 

 

March 31,

 

 

June 30,

 

 

2014

 

 

2013

 

Identifiable Tangible Assets:

 

 

 

 

 

 

 

North America

$

13,007

 

 

$

25,939

 

EMEA

 

10,441

 

 

 

10,964

 

Asia Pacific

 

2,867

 

 

 

1,698

 

 

$

26,315

 

 

$

38,601

 

 

Schedule of Revenue

The following table provides total revenue by category for the three and nine months ended March 31, 2014 and 2013, respectively, (unaudited, in thousands):

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

March 31,

 

 

March 31,

 

 

2014

 

 

2013

 

 

2014

 

 

2013

 

Revenue:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cloud services

$

7,039

 

 

$

5,200

 

 

$

19,806

 

 

$

13,429

 

Maintenance and support services

 

3,569

 

 

 

3,146

 

 

 

10,514

 

 

 

9,897

 

License

 

2,519

 

 

 

4,098

 

 

 

9,422

 

 

 

8,237

 

Professional services

 

4,899

 

 

 

3,016

 

 

 

11,631

 

 

 

9,357

 

 

$

18,026

 

 

$

15,460

 

 

$

51,373

 

 

$

40,920

 

 

Summary of Stock-Based Compensation Included in Costs and Expenses

Below is a summary of stock-based compensation included in the costs and expenses (unaudited, in thousands):

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

March 31,

 

 

March 31,

 

 

2014

 

 

2013

 

 

2014

 

 

2013

 

Stock-Based Compensation:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cost of revenue

$

92

 

 

$

28

 

 

$

244

 

 

$

87

 

Research and development

 

102

 

 

 

57

 

 

 

201

 

 

 

212

 

Sales and marketing

 

179

 

 

 

70

 

 

 

472

 

 

 

256

 

General and administrative

 

97

 

 

 

70

 

 

 

293

 

 

 

255

 

Total stock-based compensation expense:

$

470

 

 

$

225

 

 

$

1,210

 

 

$

810

 

 

Summary of Stock Option Assumptions

During the three months ended March 31, 2014 and 2013 there were 274,650 and 26,550 shares of common stock granted with a weighted-average fair value of $5.08 and $4.82 per share, respectively. During the nine months ended March 31, 2014 and 2013 there were 536,500 and 183,800 shares of common stock granted, respectively, with a weighted-average fair value of $6.09 and $3.25 per share, respectively, using the following assumptions:

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

March 31,

 

 

March 31,

 

 

2014

 

 

2013

 

 

2014

 

 

2013

 

Dividend yield

 

 

 

 

 

 

 

 

 

 

 

Expected volatility

 

80

%

 

 

85

%

 

 

80

%

 

 

88

%

Average risk-free interest rate

 

1.60

%

 

 

0.83

%

 

 

1.52

%

 

 

0.71

%

Expected life (in years)

 

4.50

 

 

 

4.50

 

 

 

4.50

 

 

 

4.50